The future of ACT in gynecology is promising, with ongoing research aimed at improving its efficacy and safety. Advances in genetic engineering, biomarker discovery, and combination therapies are expected to enhance the effectiveness of ACT and expand its application to a broader range of gynecologic cancers.
